NCT03671772View on ClinicalTrials.gov

Progression of Prodromal Markers of α-synucleinopathy Neurodegeneration in the FDRs of Patients With RBD

CompletedOBSERVATIONAL

Enrollment

170

Participants

Timeline

Start Date

September 27, 2018

Primary Completion Date

April 27, 2020

Study Completion Date

April 27, 2020

Conditions

REM Sleep Behavior DisorderNeurodegeneration

Trial Locations (1)

Unknown

Department of psychiatry, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong

All Listed Sponsors

lead

Chinese University of Hong Kong

OTHER

NCT03671772 - Progression of Prodromal Markers of α-synucleinopathy Neurodegeneration in the FDRs of Patients With RBD | Biotech Hunter | Biotech Hunter